Proellex® Pharmacokinetic Bridging Study II - Contacts and Locations

Home

Proellex® Pharmacokinetic Bridging Study II (PK)

This study has been completed.

Study NCT00620503. Last updated on May 20, 2008. Information provided by Repros Therapeutics Inc.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00620503

Locations


United States, Texas
	Healthcare Discoveries Inc.
	San Antonio, Texas, United States, 78209

Sponsors and Collaborators

Repros Therapeutics Inc.

Investigators


Study Director:	Andre vanAs, MD, PhD	Repros Therapeutics Inc.